Individual Versus Standard Follicle Stimulating Hormone Dose for Controlled Ovarian Stimulation and InseminationPredictive Factors of Ovarian Response in Ovulation Induction With Intrauterine Insemination of a Gonal-f Low-dose RegimenGONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)An Observational Study of Gonal-F Filled by Mass Pens in Multifollicular Stimulation Prior to In-vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI)A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive AgeStudy to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous CycleOvarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate DaysFSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)Hormone Evaluation in Artificial Reproductive TechnologyEffect of Recombinant Follicular Stimulating Hormone (FSH) Dosing Following Cori-follitropin Alfa a Randomized Controlled Dose-finding Study.Menopur And Rekovelle Combination StudyStudy on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy WomenFollicle-Stimulating Hormone (FSH) and the Onset of PubertyClinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ETComparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary SuppressionMenopur Mixed ProtocolA Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)Time-lapse Evaluation of Embryo Development After Stimulation With One of Two Different Gonadotrophins.Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro FertilisationFollicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile WomenPERgoveriS In Stratified Treatment for Assisted Reproductive TechniqueA Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.Ovarian Function After Use of Various Hemostatic Techniques During Treatment for EndometriomaStudy to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection ProceduresFollitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian HyperstimulationImpact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®Hormone Secretion in Transgender Males
P4844
Q61932521-12105DAA-9571-4F52-A9A5-9BD54203FA50Q61936120-6E9C6ED9-C97B-4E08-B015-AB5091E67C4CQ61936121-1AD239D6-8DC4-4E78-846C-D66316F17EA2Q61938193-159E73E1-4E04-4018-9296-1EC6FB04BF7BQ61938197-E023F2E0-6A2E-427F-9687-C07EAF09B2B9Q61938717-562D619F-49C1-4A12-B04C-20D3CBF8708DQ61955983-F2FA9F84-25DB-4C80-B89F-8302AB802B39Q61975453-0D8E3782-372B-4028-B7F9-A1FE4BE1C18DQ61979963-397DCC35-837E-46A8-80B3-8C90545FDF73Q62035416-3AEB749C-B3AB-4023-8536-2DAD591D90BAQ62054455-CD2A3056-5086-47D1-AD0D-D8A1801DB151Q62810278-A9ED2F29-734F-4AFE-A8B1-244E775CB143Q62814654-995BC3CA-5E5F-4E10-951C-EF73A5796964Q63063591-3D4658AA-375A-4744-9F4C-A35625CBC242Q63229043-12D55BD1-AF9F-4FE1-9E94-33A17A0509D1Q63318884-56F55CC0-E9F1-448B-A340-A4D50D08EA0DQ63322797-DFF3F720-629E-4CD6-A7DB-4F7F5E9B1659Q63322815-A51E5AE1-EEC3-4F75-9058-9D7FB1476AE6Q63335125-6BE44DE5-96DB-440D-9764-213C1656298AQ63336255-2B3D2BBA-D655-4ABD-A0C8-9C1CC52B5DC1Q63336871-0B8BEC34-831E-47F8-B80B-A676A3C9F6FAQ63338215-B1CEA37C-14A8-4400-BB12-46E96AD08787Q63338905-269070FA-4EB0-4BEC-B136-1CEC9EB49C23Q63398892-B0466837-4821-426D-9E86-5D7013A4EEE0Q63404232-62EC9D30-1E89-4E80-8AAF-C6D01B6C14D5Q63404350-D435C36F-69A0-4147-8A02-C40CE7CF52B2Q63578650-F7C7A5DC-10FD-4FA5-9A5B-EFC89F4B9DDFQ63583878-ED0E22BB-D667-410C-ABC4-3636126C4993Q63598170-86EAE8D7-E3B0-49FA-8268-B57FEEDF16B1Q89154755-AC712E65-18DE-42F0-A01D-3EC117D7B023
P4844
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Urofolitropin
@sh
Urofolitropin
@sr
Urofolitropina
@pt
Urofollitropin
@en
Urofollitropina
@it
urofollitropin
@nn
wroffolitropin
@cy
Урофоллитропин
@ru
يوروفوليتروبين
@ar
type
label
Urofolitropin
@sh
Urofolitropin
@sr
Urofolitropina
@pt
Urofollitropin
@en
Urofollitropina
@it
urofollitropin
@nn
wroffolitropin
@cy
Урофоллитропин
@ru
يوروفوليتروبين
@ar
altLabel
Bravelle
@cy
Bravelle
@en
FSH
@cy
FSH
@en
FSH-B
@cy
FSH-B
@en
FSH-beta
@cy
FSH-beta
@en
Fertinex
@cy
Fertinex
@en
prefLabel
Urofolitropin
@sh
Urofolitropin
@sr
Urofolitropina
@pt
Urofollitropin
@en
Urofollitropina
@it
urofollitropin
@nn
wroffolitropin
@cy
Урофоллитропин
@ru
يوروفوليتروبين
@ar
P31
P486
P592
P6366
P646
P661
P662
P665
P2067
979.425559
P2115
N0000147458
P2275
Urofollitropin
@en
P231
146479-72-3
P232
P233
CCC(C)C1C(=O)NC(C(=O)NC(C(=O)N ...... )C)C(=O)NCC(=O)N)CC(=O)N)C(C)O
P234
1S/C42H65N11O12S2/c1-6-21(4)33 ...... 64)(H,50,60)(H,51,61)(H,52,63)
P235
ZDRRIRUAESZNIH-UHFFFAOYSA-N
P2566
100.212.030